RecallDepth
Class II Ongoing

Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01

This recall is currently active, issued May 7, 2025. It was issued by Eugia Us Llc.

Company
Eugia Us Llc
Recall Initiated
April 21, 2025
Posted
May 7, 2025
Recall Number
D-0389-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
18,867 bags
Firm Location
East Windsor, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.

Distribution

USA nationwide.

Lot / Code Info

Lot #: 3TF24002A, Exp 11/30/2026

More recalls by Eugia Us Llc

View all recalls by this company →

Other recent Class II Drug recalls